Abbott Laboratories Today's Verdict
Today's verdict: Abbott Laboratories price forecast looks restrained after today’s mild pullback, with charts and historical graph data still pointing to longer-term growth but not enough near-term strength for a decisive buy or sell call right now. The price today in dollars is $94.4, and the current data suggest traders should watch whether the stock holds above near-term support before committing capital. For investors comparing cost, dividend, and payout terms, preferred shares are not the focus here, so the main decision is how to buy or sell the ticker symbol ABT online through a trading account. The graph shows a stock that can remain active for trading, but the prediction on immediate upside is measured, and the for sale setup looks more tactical than aggressive for now.
Abbott Laboratories Live Share Data
| Label | Value |
|---|---|
| Share Name & Ticker | Abbott Laboratories (ABT) |
| Exchange | NYSE |
| Currency | USD ($) |
| Current Price | $94.4 |
| Previous Close | $94.4 |
| Day's Range | $93.91 – $94.98 |
| Opening Price | $94.77 |
| Volume | 7477056 shares |
| Daily Change | -0.78 (-0.82%) |
| 52-Week High | $137.49 |
| 52-Week Low | $81.97 |
| Data As Of | Data as of 7/9/2026 12:00:00 AM |
Abbott Laboratories Key Highlights
| Label | Value |
|---|---|
| Current Price | $94.4 — reflecting a daily change of -0.78 (-0.82%). |
| Day's Range | $93.91 – $94.98 — indicating a tight intraday band. |
| 52-Week Range | $81.97 – $137.49 — showing where price today sits within the yearly range. |
| Volume vs 90-Day Average | 7477056 against 13224953 — pointing to below average trading activity. |
| Momentum | -0.82% — highlighting negative short-term momentum and moderate volatility. |
Abbott Laboratories Limited Forecast Insights
The live setup is cautious rather than bearish in a larger sense. Abbott Laboratories shares are trading well above the 52-week low of $81.97, but still notably below the $137.49 high, leaving room for movement in either direction. Today’s -0.82% decline and below-average volume argue against calling a clean breakout. If buyers defend the low-$94 area, the stock may stabilize; if that fails, traders could see a deeper test toward the lower end of the recent range.
FAQ on Abbott Laboratories Shares
Q1: What are Abbott Laboratories shares?
Answer: Abbott Laboratories shares are NYSE-listed equity in Abbott Laboratories, traded under ticker ABT. Today’s price per share is $94.4, with a -0.82% move and 7,477,056 shares changing hands. The stock sits between its 52-week low and high, showing active but measured trading.
Q2: How can I buy Abbott Laboratories shares?
Answer: To buy Abbott Laboratories shares, open a trading account with a brokerage, complete verification, deposit funds, and search for ABT on the NYSE. With the live price at $94.4, you can place a market or limit order depending on your preferred entry and cost control.
Q3: What affects the price of Abbott Laboratories shares?
Answer: Abbott Laboratories share price is affected by market demand, volume, broader healthcare sentiment, and the stock’s position within its $81.97 to $137.49 52-week range. Today’s -0.78 decline and modest volume signal that traders are still reacting to short-term supply and demand.
Q4: Does Abbott Laboratories pay dividends?
Answer: Abbott Laboratories is known by many investors for a dividend, but this live feed does not provide the payout amount or schedule. If you want the exact dividend details, check the company’s filings or your brokerage platform before making a purchase or trade.
Q5: How can I track my Abbott Laboratories shares and dividends?
Answer: You can track Abbott Laboratories shares and any dividend activity through your brokerage dashboard or investor relations updates. With ABT at $94.4 today, monitoring price changes, volume, and corporate filings gives you a clearer read on both share performance and payout records.
Q6: What factors are affecting the Abbott Laboratories share price?
Answer: The current Abbott Laboratories share price is being shaped by the -0.82% daily change, the $93.91 to $94.98 range, and volume of 7,477,056 shares versus the 90-day average of 13,224,953. That combination points to softer participation and limited momentum today.
Q7: Is Abbott Laboratories a good share to buy?
Answer: Whether Abbott Laboratories is a good share to buy depends on your time horizon and risk tolerance. At $94.4, the stock is far from its 52-week high but above the low, which can appeal to investors seeking stability rather than aggressive upside from a purchase.
Q8: Is it advisable to buy Abbott Laboratories shares today?
Answer: Buying Abbott Laboratories shares today may suit investors who want steady exposure and can tolerate short-term weakness. The current price of $94.4 is near the middle of the yearly range, but the negative daily change and below-average volume suggest patience may help.
Q9: How much does one Abbott Laboratories share cost?
Answer: One Abbott Laboratories share costs $94.4 today on the NYSE. That price is unchanged from the previous close in the live data set, and it traded between $93.91 and $94.98 during the session, giving traders a fairly tight intraday band to work with.
Q10: How to sell Abbott Laboratories shares?
Answer: To sell Abbott Laboratories shares, log into your trading account, select ABT, and choose a market or limit order. Since the stock is at $94.4 today with lighter-than-average volume, sellers may want to watch the session range closely before executing the trade.
How to Buy Abbott Laboratories Shares Step by Step
Open a trading account with a US brokerage such as Fidelity, Charles Schwab, E*TRADE, or Robinhood. Verify your account by email or phone, enable 2FA, and complete KYC checks. Then review the platform, fund the account, search ABT, and place a market or limit order.
Abbott Laboratories Actionable Financial Advice
Given Abbott Laboratories's current performance, investors should HOLD the shares if prices move ABOVE the key technical levels near $81.97 and $137.49. Monitor macroeconomic developments — interest-rate speculation, inflation trends, and Fed data — alongside the company's own sector conditions to refine your strategy.
